Immunization of preterm infants with GSK’s hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Vaccine (2018) 36:986-996. https://doi.org/10.1016/j.vaccine.2018.01.005
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2024
- Urheber
-
Omeñaca, Felix
Vázquez, Liliana
Garcia-Corbeira, Pilar
Mesaros, Narcisa
Hanssens, Linda
Dolhain, Jan
Puente Gómez, Ivonne
Liese, Johannes
Knuf, Markus
- DOI
-
10.1016/j.vaccine.2018.01.005
- URN
-
urn:nbn:de:bvb:20-opus-234450
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Omeñaca, Felix
- Vázquez, Liliana
- Garcia-Corbeira, Pilar
- Mesaros, Narcisa
- Hanssens, Linda
- Dolhain, Jan
- Puente Gómez, Ivonne
- Liese, Johannes
- Knuf, Markus
- Universität Würzburg
Entstanden
- 2024
Ähnliche Objekte (12)
Studien zur histaminsensibilisierenden Wirkung von Haemophilus Pertussis Vaccine in vitro
Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice
Nasopharyngeal Carriage in Children After the Introduction of Generalized Infant Pneumococcal Conjugate Vaccine Immunization in Germany
Intradermal immunization
Immunization Register
Immunization Register
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
Pertussis-Impfstoffkomponente
Conjugate vaccines
Immunogenicity of Biopharmaceuticals
An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine
Ertaubung nach Pertussis
Studien zur histaminsensibilisierenden Wirkung von Haemophilus Pertussis Vaccine in vitro
Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice
Nasopharyngeal Carriage in Children After the Introduction of Generalized Infant Pneumococcal Conjugate Vaccine Immunization in Germany
Intradermal immunization
Immunization Register
Immunization Register
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
Pertussis-Impfstoffkomponente
Conjugate vaccines
Immunogenicity of Biopharmaceuticals
An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine
Ertaubung nach Pertussis
Studien zur histaminsensibilisierenden Wirkung von Haemophilus Pertussis Vaccine in vitro
Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice
Nasopharyngeal Carriage in Children After the Introduction of Generalized Infant Pneumococcal Conjugate Vaccine Immunization in Germany
Intradermal immunization
Immunization Register
Immunization Register
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
Pertussis-Impfstoffkomponente
Conjugate vaccines
Immunogenicity of Biopharmaceuticals
An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine